Fetal toxicity — discontinue when pregnancy detected
Clinical alerts
Boxed warning
1 boxed warning
Mechanism of action
Selectively blocks AT1 receptor, preventing angiotensin II effects
Recorded indications
From the drug index — may include conditions studied rather than approved indications
·COVID-19
·Cardiovascular Diseases
·Hyperphosphatemia
·Chronic Kidney Disease
·Traumatic Brain Injury
Interactions
No curated interaction pairs are recorded for Candesartan. This is not a statement that none exist — check a full interaction reference before combining.
Common adverse effects
Dizziness
Back pain
Hyperkalemia
Food, alcohol & herbal
Alcohol · moderate
Additive hypotension
Pharmacokinetics
Half-life
9 hours
Protein binding
99%
Metabolised by
CYP2C9
Pregnancy & lactation
Pregnancy category
D
Sources
Assembled from: drug index, curated drug database.
